The global enzymelinked immunosorbent assay (ELISA) market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for ELISA kits in various applications such as immunology, infectious diseases, cancer and protein quantitation. The increasing number of research and development activities in the field of ELISA kits is also driving the growth of this market. The global enzymelinked immunosorbent assay (ELISA) market has been segmented on the basis of type into sandwich ELISA, indirect ELISA, multiple and portable ELISA, competitive ELISA and enzymelinked immunosorbent assay (ELISA). On the basis of application it has been segmented into immunology, infectious diseases, cancer and protein quantitation. On the basis of region it has been segmented into North America, Latin America Europe Asia Pacific Middle East & Africa.
- The ELISA market is driven by the increasing demand for accurate and reliable diagnostic tests.
- The ELISA market is driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases.
- The ELISA market is driven by the growing number of research and development activities in this field.
- The ELISA market is driven by the increasing adoption of point-of-care testing.
Industry Growth Insights published a new data on “Enzyme-Linked Immunosorbent Assay (ELISA) Market”. The research report is titled “Enzyme-Linked Immunosorbent Assay (ELISA) Market research by Types (Sandwich ELISA, Indirect ELISA, Multiple and Portable ELISA, Competitive ELISA, Enzyme-Linked Immunosorbent Assay (ELISA), By Applications (Immunology, Infectious Diseases, Cancer, Protein Quantitation, Other), By Players/Companies Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Life Technologies Corporation, ZEUS Scientific, Enzyme-Linked Immunosorbent Assay (ELISA”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enzyme-Linked Immunosorbent Assay (ELISA) Market Research Report
By Type
Sandwich ELISA, Indirect ELISA, Multiple and Portable ELISA, Competitive ELISA, Enzyme-Linked Immunosorbent Assay (ELISA
By Application
Immunology, Infectious Diseases, Cancer, Protein Quantitation, Other
By Companies
Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Life Technologies Corporation, ZEUS Scientific, Enzyme-Linked Immunosorbent Assay (ELISA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Report Segments:
The global Enzyme-Linked Immunosorbent Assay (ELISA) market is segmented on the basis of:
Types
Sandwich ELISA, Indirect ELISA, Multiple and Portable ELISA, Competitive ELISA, Enzyme-Linked Immunosorbent Assay (ELISA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immunology, Infectious Diseases, Cancer, Protein Quantitation, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ortho-Clinical Diagnostics
- Thermo Fisher Scientific
- Life Technologies Corporation
- ZEUS Scientific
- Enzyme-Linked Immunosorbent Assay (ELISA
Highlights of The Enzyme-Linked Immunosorbent Assay (ELISA) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sandwich ELISA
- Indirect ELISA
- Multiple and Portable ELISA
- Competitive ELISA
- Enzyme-Linked Immunosorbent Assay (ELISA
- By Application:
- Immunology
- Infectious Diseases
- Cancer
- Protein Quantitation
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enzyme-Linked Immunosorbent Assay (ELISA) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An enzyme-linked immunosorbent assay (ELISA) is a laboratory technique used to measure the amount of a specific antigen or antibody in a sample. The antigen or antibody is linked to an enzyme, which allows the immune system to recognize and bind to it. The ELISA then measures how much of the antigen or antibody is present in the sample.
Some of the key players operating in the enzyme-linked immunosorbent assay (elisa) market are Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Life Technologies Corporation, ZEUS Scientific, Enzyme-Linked Immunosorbent Assay (ELISA.
The enzyme-linked immunosorbent assay (elisa) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Enzyme-Linked Immunosorbent Assay (ELISA) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Enzyme-Linked Immunosorbent Assay (ELISA) Market - Supply Chain
4.5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast
4.5.1. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Absolute $ Opportunity
5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Type
5.3.1. Sandwich ELISA
5.3.2. Indirect ELISA
5.3.3. Multiple and Portable ELISA
5.3.4. Competitive ELISA
5.3.5. Enzyme-Linked Immunosorbent Assay (ELISA
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Application
6.3.1. Immunology
6.3.2. Infectious Diseases
6.3.3. Cancer
6.3.4. Protein Quantitation
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Demand Share Forecast, 2019-2026
9. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Application
9.4.1. Immunology
9.4.2. Infectious Diseases
9.4.3. Cancer
9.4.4. Protein Quantitation
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Type
9.7.1. Sandwich ELISA
9.7.2. Indirect ELISA
9.7.3. Multiple and Portable ELISA
9.7.4. Competitive ELISA
9.7.5. Enzyme-Linked Immunosorbent Assay (ELISA
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Enzyme-Linked Immunosorbent Assay (ELISA) Demand Share Forecast, 2019-2026
10. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Application
10.4.1. Immunology
10.4.2. Infectious Diseases
10.4.3. Cancer
10.4.4. Protein Quantitation
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Type
10.7.1. Sandwich ELISA
10.7.2. Indirect ELISA
10.7.3. Multiple and Portable ELISA
10.7.4. Competitive ELISA
10.7.5. Enzyme-Linked Immunosorbent Assay (ELISA
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Demand Share Forecast, 2019-2026
11. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Application
11.4.1. Immunology
11.4.2. Infectious Diseases
11.4.3. Cancer
11.4.4. Protein Quantitation
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Type
11.7.1. Sandwich ELISA
11.7.2. Indirect ELISA
11.7.3. Multiple and Portable ELISA
11.7.4. Competitive ELISA
11.7.5. Enzyme-Linked Immunosorbent Assay (ELISA
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Demand Share, 2019-2026
12. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Application
12.4.1. Immunology
12.4.2. Infectious Diseases
12.4.3. Cancer
12.4.4. Protein Quantitation
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Type
12.7.1. Sandwich ELISA
12.7.2. Indirect ELISA
12.7.3. Multiple and Portable ELISA
12.7.4. Competitive ELISA
12.7.5. Enzyme-Linked Immunosorbent Assay (ELISA
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Demand Share, 2019-2026
13. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Application
13.4.1. Immunology
13.4.2. Infectious Diseases
13.4.3. Cancer
13.4.4. Protein Quantitation
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Volume Forecast by Type
13.7.1. Sandwich ELISA
13.7.2. Indirect ELISA
13.7.3. Multiple and Portable ELISA
13.7.4. Competitive ELISA
13.7.5. Enzyme-Linked Immunosorbent Assay (ELISA
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market: Market Share Analysis
14.2. Enzyme-Linked Immunosorbent Assay (ELISA) Distributors and Customers
14.3. Enzyme-Linked Immunosorbent Assay (ELISA) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ortho-Clinical Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Life Technologies Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ZEUS Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Enzyme-Linked Immunosorbent Assay (ELISA
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financia